Patents by Inventor Peter J. Newman
Peter J. Newman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12065876Abstract: A motorized window treatment may provide a low-cost solution for controlling the amount of daylight entering a space through a window. The window treatment may include a covering material (e.g., a cellular shade fabric or a roller shade fabric), a drive assembly for raising and lowering the covering material, and a motor drive unit including a motor configured to drive the drive assembly to raise and lower the covering material. The motorized window treatment may comprise one or more battery packs configured to receive batteries for powering the motor drive unit. The batteries may be located out of view of a user of the motorized window treatment (e.g., in a headrail or in a battery compartment). The motorized window treatment may use various power-saving methods to lengthen the lifetime of the batteries, e.g., to reduce the motor speed to conserve additional battery power and extend the lifetime of the batteries.Type: GrantFiled: February 28, 2022Date of Patent: August 20, 2024Assignee: Lutron Technology Company LLCInventors: Jason O. Adams, Edward J. Blair, Andrew Karl Cooney, Soumya Jain, David A. Kirby, Stephen Lundy, Justin J. Mierta, Daniel W. Mistarz, Robert C. Newman, Jr., Peter W. Ogden, Jr., Jonathan L. Roe, Chen Ming Wu, Justin M. Zernhelt, Samuel F. Chambers
-
Patent number: 12044069Abstract: A motorized window treatment for controlling the amount of daylight entering a space through a window includes a covering material, a drive shaft, and a motor coupled to the drive shaft for raising and lowering the covering material. The window treatment also includes a spring assist unit for assisting the motor by providing a torque that equals the torque provided by the weight on the cords that lift the covering material at a position midway between fully-open and fully-closed positions to minimize motor usage and conserve battery life. The window treatment may comprise a photosensor for measuring the amount of daylight outside the window and temperature sensors for measuring the temperatures inside and outside of the window. The position of the covering material may be automatically controlled in response to the photosensor and the temperature sensors, or in response to an infrared or radio-frequency remote control.Type: GrantFiled: September 26, 2022Date of Patent: July 23, 2024Assignee: Lutron Technology Company LLCInventors: Jason O. Adams, Edward J. Blair, Andrew Karl Cooney, Soumya Jain, David A. Kirby, Stephen Lundy, Justin J. Mierta, Daniel W. Mistarz, Robert C. Newman, Jr., Peter W. Ogden, Jr., Jonathan L. Roe, Chen Ming Wu, Justin M. Zernhelt
-
Publication number: 20220211017Abstract: A transgenic mouse comprising T30A, S32P, Q33L, N39D, and M470Q mutations in GPIIIa, as well as methods for making the transgenic mouse and methods for using the transgenic mouse to screen test compounds are described.Type: ApplicationFiled: February 9, 2022Publication date: July 7, 2022Inventors: Peter J. Newman, Huiying Zhi
-
Patent number: 11266129Abstract: A transgenic mouse comprising T30A, S32P, Q33L, N39D, and M470Q mutations in GPIIIa, as well as methods for making the transgenic mouse and methods for using the transgenic mouse to screen test compounds are described.Type: GrantFiled: November 5, 2019Date of Patent: March 8, 2022Inventors: Peter J. Newman, Huiying Zhi
-
Publication number: 20210127648Abstract: A transgenic mouse comprising T30A, S32P, Q33L, N39D, and M470Q mutations in GPIIIa, as well as methods for making the transgenic mouse and methods for using the transgenic mouse to screen test compounds are described.Type: ApplicationFiled: November 5, 2019Publication date: May 6, 2021Inventors: Peter J. Newman, Huiying Zhi
-
Patent number: 7058984Abstract: According to this invention, a conventional pair of golf gloves is provided with pads across the palm portions thereof which abut the grip portion of a golf club shaft to automatically align the shaft for proper gripping. The guide pads are so positioned across the palm portions of the gloves that when the golf club head is soled on the ground and the upper and lower gripping hands of a golfer wearing the gloves receive the grip portion of the club shaft across the palms of the glove and against the pads, the shaft will lie diagonally across the roots of the fingers and when the hands are closed around the shaft with the guide pads cradling the grip portion of the golf club distal from the golf club head, an automatic proper gripping of the golf club will be insured. The guide pads are substantially parallel to the transverse creases of the hand, lying diagonally across the roots of the fingers. The pad on the first glove spans substantially the entire palm of the hand.Type: GrantFiled: September 18, 2003Date of Patent: June 13, 2006Inventor: Peter J. Newman
-
Patent number: 6087331Abstract: Novel, substantially isolated isoforms of human platelet-endothelial cell adhesion molecule-1's, DNAs coding for transcripts that encode the novel isoforms and others, including a previously identified soluble isoform, methods of using such DNAs to make isoforms by expressing the DNA's, and promoter segments controlling transcription of human platelet-endothelial cell adhesion molecule-1 genes are provided. The novel isoforms differ from the complete human platelet-endothelial cell adhesion molecule-1's in lacking one or more segments near the C-terminus encoded by exons 10-15 of the genes for the full length molecules and arise in vivo from alternative splicing of the transcript from the genes.Type: GrantFiled: June 7, 1995Date of Patent: July 11, 2000Assignee: The Blood Center of Southeastern WisconsinInventors: Peter J. Newman, Richard J. Gumina, Nancy Kirshbaum
-
Polynucleotides encoding platelet endothelial cell adhesion molecule (PECAM-1) and fragments thereof
Patent number: 6020188Abstract: A glycoprotein, PECAM-1, and variants thereof can be obtained by expression in a transformed host cell of a polynucleotide coding for the glycoprotein or a variant polypeptide. PECAM-1 can also be isolated from cellular sources. An antibody specific for PECAM-1 or a PECAM variant can be produced via recombinant techniques, or can be obtained from a hybridoma.Type: GrantFiled: November 16, 1994Date of Patent: February 1, 2000Assignee: Blood Center Research FoundationInventor: Peter J. Newman -
Patent number: 5972601Abstract: Isolated polynucleotide molecules and peptides encoded by these molecules can be used in the analysis of alloantigen phenotypes, as well as in diagnostic and therapeutic applications, relating to human platelet Pen polymorphism. By analyzing genomic DNA or amplified genomic DNA, or amplified cDNA derived from platelet mRNA, it is possible to type glycoprotein GPIIIa with regard to the Pen polymorphism, for example, in the context of diagnosing and treating clinical syndromes associated with GPIIIa-related immune responses.Type: GrantFiled: June 7, 1995Date of Patent: October 26, 1999Assignee: Blood Center Research Foundation, Inc.Inventor: Peter J. Newman
-
Patent number: 5917030Abstract: A glycoprotein, PECAM-1, and variants thereof can be obtained by expression in a transformed host cell of a polynucleotide coding for the glycoprotein or a variant polypeptide. PECAM-1 can also be isolated from cellular sources. An antibody specific for PECAM-1 or a PECAM variant can be produced via recombinant techniques, or can be obtained from a hybridoma.Type: GrantFiled: June 7, 1995Date of Patent: June 29, 1999Assignee: The Blood Center Research Foundation, Inc.Inventor: Peter J. Newman
-
Patent number: 5780229Abstract: Isolated polynucleotide molecules and peptides encoded by these molecules can be used in the analysis of alloantigen phenotypes, as well as in diagnostic and therapeutic applications, relating to human platelet Pen polymorphism. By analyzing genomic DNA or amplified genomic DNA, or amplified cDNA derived from platelet mRNA, it is possible to type glycoprotein GPIIIa with regard to the Pen polymorphism, for example, in the context of diagnosing and treating clinical syndromes associated with GPIIIa-related immune responses.Type: GrantFiled: June 7, 1995Date of Patent: July 14, 1998Assignee: The Blood Center Research Foundation, Inc.Inventor: Peter J. Newman
-
Patent number: 5670337Abstract: Isolated polynucleotide molecules, and peptides encoded by these molecules, can be used in the analysis of alloantigen phenotypes, as well as in diagnostic and therapeutic applications relating to human platelet Pl.sup.A polymorphism. In this vein, a method for typing blood cell and platelet membrane glycoproteins entails an analysis of amplified cDNA, encoded by platelet and red blood cell mRNA.Type: GrantFiled: February 21, 1995Date of Patent: September 23, 1997Assignee: Blood Center Research FoundationInventors: Peter J. Newman, Richard H. Aster
-
Patent number: 5668012Abstract: Novel, substantially isolated isoforms of human platelet-endothelial cell adhesion molecule-1's, DNAs coding for transcripts that encode the novel isoforms and others, including a previously identified soluble isoform, methods of using such DNAs to make isoforms by expressing the DNA's, and promoter segments controlling transcription of human platelet-endothelial cell adhesion molecule-1 genes are provided. The novel isoforms differ from the complete human platelet-endothelial cell adhesion molecule-1's in lacking one or more segments near the C-terminus encoded by exons 10-15 of the genes for the full length molecules and arise in vivo from alternative splicing of the transcript from the genes.Type: GrantFiled: July 5, 1994Date of Patent: September 16, 1997Assignee: The Blood Center Research Foundation, Inc.Inventors: Peter J. Newman, Richard J. Gumina, Nancy Kirshbaum
-
Patent number: 5652357Abstract: Isolated polynucleotide molecules and peptides encoded by these molecules can be used in the analysis of alloantigen phenotypes, as well as in diagnostic and therapeutic applications, relating to human platelet Bak polymorphism. By analyzing genomic DNA or amplified genomic DNA, or amplified cDNA derived from platelet mRNA, it is possible to type glycoprotein GPIIb with regard to the Bak polymorphism, for example, in the context of diagnosing and treating clinical syndromes associated with GPIIb-related immune responses.Type: GrantFiled: October 7, 1994Date of Patent: July 29, 1997Assignee: Blood Center Research FoundationInventors: Peter J. Newman, Richard H. Aster
-
Patent number: 5516634Abstract: Based on the discovery of the amino acid and nucleotide differences which distinguish the Br.sup.a and Br.sup.b allelic forms of the membrane glycoprotein GPIa, and which comprise the diallelic Br platelet alloantigen system, compositions and methods are provided for determining the Br genotype and phenotype of individuals. Also provided, on the basis of this discovery, are compositions and methods for treating disorders associated with Br alloantigen incompatibility, such as the bleeding disorders post-transfusion purpura, post-transfusion platelet refractoriness, and neonatal alloimmune thrombocytopenic purpura. The two allelic forms of GPIa differ by a single amino acid. The Br.sup.a allelic form has Lys at position 505 in the sequence of the mature GPIa. The Br.sup.b allelic form has Glu at the same position. This amino acid difference is due to a single change, from A for the Br.sup.a allele to G for the Br.sup.b allele, in the GPIa gene.Type: GrantFiled: June 30, 1993Date of Patent: May 14, 1996Inventors: Peter J. Newman, Sentot S. Santoso
-
Patent number: 5436163Abstract: Isolated polynucleotide molecules and peptides encoded by these molecules can be used in the analysis of alloantigen phenotypes, as well as in diagnostic and therapeutic applications, relating to human platelet Bak polymorphism. By analyzing genomic DNA or amplified genomic DNA, or amplified cDNA derived from platelet mRNA, it is possible to type glycoprotein GPIIb with regard to the Bak polymorphism, for example, in the context of diagnosing and treating clinical syndromes associated with GPIIb-related immune responses.Type: GrantFiled: December 1, 1989Date of Patent: July 25, 1995Assignee: The Blood Center of Southeastern WisconsinInventors: Peter J. Newman, Richard H. Aster
-
Patent number: 5391714Abstract: Antibodies which distinguish between the Pl.sup.A1 form of GPIIIa and the Pl.sup.A2 form of GPIIIa can be used in the analysis of alloantigen phenotypes, as well as in diagnostic applications relating to human platelet Pl.sup.A polymorphism.Type: GrantFiled: November 22, 1991Date of Patent: February 21, 1995Assignee: The Blood Center of Southeastern WisconsinInventors: Peter J. Newman, Richard H. Aster
-
Patent number: 5264554Type: GrantFiled: January 19, 1990Date of Patent: November 23, 1993Assignee: The Blood Center of Southeastern Wisconsin, Inc.Inventor: Peter J. Newman
-
Patent number: 5091302Abstract: Isolated polynucleotide molecules, and peptides encoded by those molecules, can be used in the analysis of alloantigen phenotypes, as well as in diagnostic and therapeutic applications relating to human platelet Pl.sup.A polymorphism. In this vein, a method for typing blood cell and platelet membrane glycoproteins entails an analysis of amplified cDNA, encoded by platelet and red blood cell mRNA.Type: GrantFiled: April 27, 1989Date of Patent: February 25, 1992Assignee: The Blood Center of Southeastern Wisconsin, Inc.Inventors: Peter J. Newman, Richard H. Aster